1. Home
  2. SMHI vs IPHA Comparison

SMHI vs IPHA Comparison

Compare SMHI & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEACOR Marine Holdings Inc.

SMHI

SEACOR Marine Holdings Inc.

HOLD

Current Price

$7.47

Market Cap

188.9M

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.26

Market Cap

119.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMHI
IPHA
Founded
1989
1999
Country
United States
France
Employees
N/A
174
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.9M
119.1M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
SMHI
IPHA
Price
$7.47
$1.26
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
140.8K
17.6K
Earning Date
04-29-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
62.41
N/A
EPS
N/A
N/A
Revenue
$173,783,000.00
N/A
Revenue This Year
N/A
$181.17
Revenue Next Year
$9.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.63
$1.18
52 Week High
$8.17
$2.63

Technical Indicators

Market Signals
Indicator
SMHI
IPHA
Relative Strength Index (RSI) 52.34 37.26
Support Level $7.18 $1.18
Resistance Level $7.86 $1.88
Average True Range (ATR) 0.40 0.09
MACD -0.00 -0.01
Stochastic Oscillator 61.44 25.63

Price Performance

Historical Comparison
SMHI
IPHA

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that (i) deliver cargo and personnel to offshore installations, including offshore wind farms, (ii) assist offshore operations for production and storage facilities, (iii) provide construction, well work-over, offshore wind farm installation and decommissioning support and (iv) carry and launch equipment used underwater in drilling and well installation, maintenance, inspection and repair. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America, with the majority of revenue deriving from the Africa and Europe segment.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: